The Wall Street Journal

How a surfie who never finished uni became a biotech billionaire

How a surfie who never finished uni became a biotech billionaire
Bob Duggan is now said to be worth $25.6 billion. (Image: Summit Therapeutics)
The Wall Street Journal
By David WainerThere is a myth that making money in biotechnology stocks requires an advanced degree. But Bob Duggan, an avid surfie who never graduated from university, has proven that notion wrong. Twice.Duggan’s latest investment, Summit Therapeutics, has become one of the industry’s greatest bets in recent years. The stock is up more than 1,000% in the past 12 months thanks to data from a late-stage trial that showed that its drug, Ivonescimab, beat Merck’s blockbuster cancer drug Keytruda in patients with a form of l...

More Health

Oceania forecasts sales lift as it targets debt
Property

Oceania forecasts sales lift as it targets debt

It said sales applications had lifted 23% between July and August.

Gregor Thompson 16 Sep 2025
F&P Healthcare urges Govt to shut patent loophole
Markets

F&P Healthcare urges Govt to shut patent loophole

The company says the current patent loophole threatens its NZ operations.

Michael Neilson 16 Sep 2025
F&P Healthcare one step closer to new Karaka campus
Policy

F&P Healthcare one step closer to new Karaka campus

Auckland Council has approved a request to rezone nearly 90ha going to hearings.

Oliver Lewis 12 Sep 2025
How RFK Jnr's Medicare reform could aid this NZ firm
Markets

How RFK Jnr's Medicare reform could aid this NZ firm

'Wild west' conditions hampered its US push. They could be changing.